Skip to content
RhenalisPharmaExample company

Rhenalis Pharma UK Limited · London, since 1912, 11,000 people, 15 sites in 14 countries

Getting started with AI · Pharma & Biotech

How a pharma group gets started with AI

Rhenalis doesn’t exist. Everything else on this page will feel familiar.

Rhenalis develops and makes its own medicines. This page is set in one plant: in Basel, it makes film-coated tablets, hard capsules, prolonged-release pellets and granules in sachets. No batch leaves the plant without a certificate from the Qualified Person.

demi turns your systems into one record, carries over your rights and lets AI agents prepare the routine work. First the data, then the rights, then the AI. A person always approves.

What five use cases free up

+641 h per yearEstimate, not a promise≈ €41,665 per year, calculated cautiously
RhenalisPrescription only medicine

FT-500

Film-coated tablets 500 mg

30 film-coated tablets · For oral use. Read the package leaflet.

Contents
30 tablets
Storage
do not store above 25 °C

PC 09521234005001
SN 7Q3K9X2M4T8W
Lot 26-0409
EXP 10.2029

Rhenalis Pharma AG · 4058 Basel · Switzerland

The folding box of batch 26-0409, packed on 10 November, now in quarantine. We leave out the trade name and the active substance: a made-up medicine should not resemble a real one. Every value leads to its source.

The problem

Wednesday, 6:50 am: one press, four batches, 1.9 million tablets

There is a new deviation at QA Operations in the Basel plant. Overnight, the breaking force of film-coated tablet FT-500 at tablet press T3 fell below the IPC limit. The shift stopped the press at 3:35 am and put batch 26-0412 on hold.

The questions are always the same: Has this happened before? Did the CAPA from back then work? Which batches ran under the same conditions? Where the answers are:

In the QMSTwo similar cases from 2025. One is called “Hardness too low”, the other “Capping after punch change”.

In the MESWhich batches ran on T3 since the punch change on 2 November, and with which IPC values.

In the DMSWhether the CAPA from 2025 was ever checked for effectiveness.

Until now, QA spends two days searching three systems and old PDF reports. For that long, four batches sit in quarantine and two markets wait for goods.

FromTableting shift lead, night shift
ToQA Operations, Basel plant
SubjectAB-26-0731: breaking force FT-500 below IPC limit, batch 26-0412

IPC tableting, press T3eBR 26-0412 · step 7.3 · night shift

IPC values of batch 26-0412 at press T3 during the night
1:30Breaking force Ø 101 N · weight 651 mg
2:00Breaking force Ø 97 N · weight 650 mg
2:30Breaking force Ø 92 N · weight 652 mg
3:00Breaking force Ø 88 N, below 90 N · weight 651 mg
3:30Breaking force Ø 86 N, below 90 N · press stopped

Target: breaking force 90 to 160 N · weight 650 mg ±5%

  1. 1IPC value below the limit, press T3
  2. 2similar deviations at T3 in 2025
  3. 1CAPA from back then without an effectiveness check
  4. 4batches since the punch change on 2 November
  5. 1.9 mtablets in quarantine
  6. 30days the SOP allows until the investigation is closed

What happens here every month

  1. 4PQR reports
  2. 25deviations
  3. 2audits and inspections
  4. 10trace requests
  5. 8process devi­ations

Together that is 3,744 hours a year, about 2.1 full-time roles, for these five processes alone.

What hurts there

  1. 01
    Deviations with no memory

    Whether an error has happened before and whether the CAPA worked is in old reports. Recurring deviations are spotted late, sometimes only in the inspection.

  2. 02
    The PQR ties up QA for weeks

    For each product, a year of batches, test results, deviations, change controls and stability data: every Product Quality Review starts with collecting.

  3. 03
    The next inspection is coming

    An authority or a partner wants to see SOPs, training records, qualifications and audit trails, immediately and without gaps.

What demi does · An example

The report on day 3 instead of day 12

This is how the same Wednesday runs once deviations are live, from week 1.

  1. The deviation

    demi reads AB-26-0731 and the electronic batch record of 26-0412. From 2:30 am, the breaking force falls; weight and compression force stay within target.

    AB-26-0731eBR 26-0412
  2. The earlier cases

    In the QMS, demi finds two similar deviations at T3: AB-25-0388 in March and AB-25-0912 in October 2025. Both came a few days after a punch change, and both are worded differently there.

    AB-25-0388AB-25-0912
  3. The CAPA

    CAPA-25-041 was meant to change the start-up check of new punch sets. It has been closed since January. There is no effectiveness check.

    CAPA-25-041SOP-PR-022
  4. The batches

    Since the punch change on 2 November, four batches have run on T3: 26-0398, 26-0403, 26-0409 and 26-0412. In 26-0409, the breaking force is close to the limit but within target. It is already packed.

    4 batchesPunch set S-T3-07
  5. The draft

    A report on the template from SOP-QA-014: sequence of events, impact assessment with the LIMS values for dissolution and friability, classification “major” as a proposal with reasoning, plus a CAPA draft with an effectiveness check after three batches.

    Report draftSource for every sentence
  6. The decision

    QA classifies the deviation as “major”, sets the CAPA and orders an additional friability test for 26-0412. QA decides on the four batches once the results are in. Only the Qualified Person may certify.

    A person decidesAudit trail

A deviation with a history and four batches does not happen every day. Further down, we calculate with an ordinary deviation and leave the quarantine out: four hours, 25% of that, times 0.6 is 36 minutes freed up per deviation.

2Rights

The org chart becomes the permission system

In a GMP plant, it is set down who may do what: who adds to a batch record, who closes a deviation, who certifies a batch. In demi, that stays exactly the same. The Qualified Person certifies, QA closes deviations, and only those who need the dossier and manufacturing process see them.

Basel plant: 1,240 people, seven departments

The earlier a department handles a batch, the further forward it stands: first Supply Chain with the active substance and excipients, last Regulatory Affairs with the dossier. Underlined in pink: departments that see the dossier and manufacturing process in full.

Plant management and staff functions 64Plant management 3 · EHS 14 · Controlling 9 · HR 12 · IT & Automation 18 · Assistants 8
  • 1Supply Chain 96
    • Purchasing 14
    • Production plan­ning 22
    • Warehouse & logistics 60
  • 2Manufacturing 520
    • Granulation & pellets 148
    • Tableting 128
    • Coating & capsules 84
    • Packaging 160
  • 3Engineering 150
    • Main­tenance 92
    • Qualification 26
    • Projects 32
  • 4Quality Con­trol 182
    • QC lab 96
    • Micro­biology 34
    • Stability 28
    • IPC & sampling 24
  • 5Quality Assur­ance 128
    • QA Operations 46
    • QA systems 34
    • Validation & CSV 18
    • Audits & suppliers 16
    • Documents 8
    • Qualified Persons 6
  • 6Process Develop­ment 64
    • Formulation & scale-up 30
    • Technology trans­fer 18
    • Process data 16
  • 7Regulatory Affairs CMC 36
    • Dossier 24
    • Artwork & labelling 12

64 + 96 + 520 + 150 + 182 + 128 + 64 + 36 = 1,240 people at the Basel plant

Who opens which room

WhoDossier & processBatches & eBRLab & stabilityDeviations & CAPASuppliersHRApproves
Qualified Personreadsreadsreadsreadsreads–Certifies the batch
QA Operationsreadschecksreadseditsreads–Closes the deviation
Formulation & scale-upeditsreadsreadsreads––New process version
Regulatory Affairs CMCedits–release datareads––Variation to the authority
Tabletingmanufacturing instructionsown lineIPCreports––eBR step of the shift
QC labtest methodreadseditsreads––Test result
Purchasing––incoming inspection–edits–Order
HR–––––edits–
Auditor, time-limited access–selectionselectionselectionselection––
Process agent, AI coworkermanufacturing instructionsreadsIPC–––Never
Deviation agent, on someone’s behalfAs much as the person who starts it. No more.Never

Every room has keys. They come from your systems and never multiply on their own.

Whoever develops the process, files it with the authority or certifies the batch sees the whole dossier. Tableting sees the manufacturing instructions for its line, the lab the test method. If the shift lead starts the deviation agent, it sees no dossier.

An agent carries the keys of the person it works for. An AI coworker has its own, and always a person who is accountable for it. Every access is in the audit trail.

RhenalisPharmaExample company

Medicines from Basel. Since 1912.

Solid dosage forms from Basel: around 1,100 batches a year, none without a certificate

From a lab on the Rhine to a group

  1. Two pharmacists found a lab for tablets and powders in Kleinbasel. They supply pharmacies along the Upper Rhine.

  2. The first in-house substance reaches the market as a tablet. On the edge of Basel, the plant for solid dosage forms is built.

  3. Rhenalis goes public and takes over plants in Lyon and Milan. Research in Leiden joins in 1998, Boston in 2006.

  4. 11,000 people at 15 sites in 14 countries. The Basel plant runs granulation, pelletising, six tablet presses, three coaters, capsule filling and four packaging lines with serialisation.

Profile

Founded
1912 in Basel
People
11,000 in the group, 1,240 at the Basel plant. All departments of the plant in the org chart
Basel plant
Solid dosage forms: granulation, pelletising, six rotary presses, three coaters, two capsule filling machines, four packaging lines with serialisation
Markets
Medicines in over 70 countries, supplied to wholesalers and hospitals
Revenue
Around CHF 4.3 billion in the group
Output
Around 1,100 batches a year at the Basel plant
Works to
GMP, Ph. Eur., Annex 11 and 21 CFR Part 11
Systems
ERP, MES with eBR, LIMS, QMS, DMS, process database

Sites

  • LondonUnited Kingdom · Sales and clinical trialsRhenalis Pharma UK Limited
  • BaselSwitzerland · Group headquarters, solid dosage forms plantRhenalis Pharma AG
  • LyonFrance · PlantRhenalis Pharma France SAS
  • MilanItaly · PlantRhenalis Pharma Italia S.p.A.
  • BarcelonaSpain · Sales and clinical trialsRhenalis Pharma España S.L.U.
  • BostonUnited States · Research and developmentRhenalis Pharma North America, Inc.
  • LeidenNetherlands · Research and developmentRhenalis Pharma Nederland B.V.
  • WarsawPoland · Clinical trialsRhenalis Pharma Polska Sp. z o.o.
  • São PauloBrazil · SalesRhenalis Pharma do Brasil S.A.
  • ShanghaiChina · Research and salesRhenalis Pharma (Shanghai) Co., Ltd.
  • Hong KongChina · Licences for the regionRhenalis Pharma (Hong Kong) Limited
  • DubaiUAE · Sales for the regionRhenalis Pharma Middle East L.L.C.
  • RiyadhSaudi Arabia · SalesRhenalis Pharma Saudi Arabia LLC
  • CairoEgypt · SalesRhenalis Pharma Egypt S.A.E.
  • JohannesburgSouth Africa · SalesRhenalis Pharma South Africa (Pty) Ltd.

Four dosage forms at the Basel plant

  • FTFilm-coated tabletscoated, 100 to 1,000 mg
  • HKHard capsulesfilled with powder or pellets
  • RPProlonged-release pelletsactive substance released over 12 to 24 hours
  • GBGranules in sachetsdissolved in water to take

The payoff

Example calculation: five use cases free up 641 hours a year

≈ €41,665 per yearEstimate, not a promise
StartUse caseVolume per monthShareToday per yearFreed upValue per year
1PQR: every batch of the year in one draftQA, Quality Control4 × 32 h30%1,536 h276 h€17,940
2Settle a GMP deviation with every past caseQA, Manufacturing25 × 4 h25%1,200 h180 h€11,700
3Audit evidence in one placeQA, Audits & suppliers2 × 16 h30%384 h69 h€4,485
4Trace batches and serial numbersQA, Supply Chain10 × 2 h40%240 h58 h€3,770
5Flag process drift before scrap appearsManufacturing, Process Development8 × 4 h25%384 h58 h€3,770
Total3,744 h641 h€41,665

Of 3,744 hours, we count 641: volume times time times twelve months, then only the cautious share of that, times 0.6 for partly digital processes. That is about 0.4 full-time roles. Calculated at €65 per hour: €49.50 labour cost in manufacturing according to Destatis, plus workplace, IT and overheads. For PQR and deviations: demi drafts, QA assesses and signs. Does a number not fit your company? You change every one in the configurator.

Office & Lab <=> Plant Floor

Where demi works at Rhenalis: nine of 14 stations

demi can work at all 14 stations. Pick a use case and see which ones it touches.

Office & Lab

  1. O2Development & transfer 
  2. O3Deviation, CAPA & PQR1 2
  3. O5Audits & suppliers3
  4. O6QC lab & stability1
  5. O8SOPs & change control3
One record. Every fact runs both ways.

Plant Floor

  1. S1Goods in & sampling4
  2. S2Weighing & granulation5
  3. S3Tableting2 5
  4. S5Packaging & serialisation4
  5. S6Quarantine & shipping4
  • demi works here
  • Next at Rhenalis
  • demi can work here too
  • Path: batch 26-0409 from goods in through granulation, press T3, coater and lab into quarantine

The start

How Rhenalis starts: the PQR first, the running press last

Which systems and use cases join in the first 90 days
The first 90 daysDay 1Week 1Weeks 2 to 4Months 2 and 3
Systems
LIMS, QMSRead-only, via a small connector in their own network
MES with eBR, ERPRead-only: batches, weighings, IPC values
DMSRead-only: SOPs, reports, evidence
Process databaseRead-only: presses, granulators, coaters
Use cases
1 PQRFrom week 1. QA assesses and signs
2 DeviationsFrom week 1. QA classifies
3 AuditsHead of QA approves the package
4 TraceabilityQA decides on the hold
5 Process driftAlerts go to the shift, a person decides
Writing back
Into the QMSAfter validation, with electronic signature

Why the PQR comes first

It only needs reading: LIMS and QMS from day 1, the MES from week 1. For each product, it links batch, test result, deviation and change control. Every other use case stands on that link. And a draft stays a draft: QA assesses and signs as before.

Why the running press comes last

Process monitoring learns the normal state of each press from months of process data, and its alerts go into the running shift. That needs the process database and a completed validation. After the first four use cases, both are in place.

What Rhenalis does itself

  • IT & AutomationTwo days for the connections
  • Validation & CSVRisk assessment and test plan under Annex 11, weeks 2 to 4
  • Head of QAOne hour a week

1Data

Six systems become one record

1,271entries
1,415links
6systems

An excerpt from Rhenalis’s record, Basel plant.

AConnected

  • ERP
    Materials, goods receipts, batches, deliveries, wholesalersThe delivery note shows the batch, not a serial number
  • MES
    Electronic batch record, weighings, IPC values, changeovers, serialisationThe punch change is free text in the setup log
  • LIMS
    Samples, test results, specifications, stabilityHere the batch is called FT500-0409
  • QMS
    Deviations, CAPA, change controls, complaints, auditsThe same cause is worded three different ways
  • DMS
    SOPs, manufacturing and test instructions, validation reports, training recordsReports up to 2019 only as scanned PDFs
  • Process data­base
    Compression forces, speed, moisture, temperatures, every secondKnows equipment, but no batches

Nothing gets replaced. Running different systems? demi connects to every ERP, MES and LIMS, from the big standard packages to in-house builds. At first, demi only reads. A person connects a system after seeing who will read what.

BHeld together

The same batch. Six systems. Now one entry.
Batch
26-0409
Product
FT-500, film-coated tablet 500 mg
Manufacturing instructions
HV-FT500 v9
Press
T3
Status
Quarantine
Batch file of batch 26-0409 with target, actual and source of every value
ParameterTargetActualSource
Header
Batch 26-0409Finished product FT-500, 30 film-coated tablets per packERP
Manufacturing orderHA-26-1187, 6 to 10 NovMES
Manufacturing instructionsHV-FT500 version 9DMS, MES
Expiry date10.2029, 36 months per marketing authorisationERP
Tableting on press T3, punch set S-T3-07
Weight650 mg ±5%Ø 651 mgMES, IPC balance
Breaking force90 to 160 NØ 104 N, min. 93 NMES, hardness tester
Thickness6.2 to 6.6 mm6.4 mmMES
Disintegration timemax. 15 min6 minMES
Compression force14 to 20 kNØ 17.8 kNProcess database, T3
Lab, sample L-26-21877
Assay95.0 to 105.0%99.6%LIMS, SP-FT500 Rev. 6
Dissolution at 30 minmin. 80% (Q)91%LIMS, Ph. Eur. 2.9.3
Uniformity of dosage unitsAV max. 154.2LIMS, Ph. Eur. 2.9.40
Water contentmax. 3.0%2.1%LIMS
Packaging and release
Packaging, line V230 tablets, 3 blisters of 1015,912 folding boxesMES
Serial numbersone per folding box15,912 reportedMES, serialisation
Deviation AB-26-0731, press T3Openclosed before certificationopen, impact assessment under wayQMS
Certificationby the Qualified Person, after AB-26-0731 is closedQMS
Target value, manufacturing instructions90 to 160 NHV-FT500 v9, step 7.3
Actual value, batch 26-0412Ø 86 NIPC 3:30, press T3
Finding F-26-21126-0409 within target, close to the limitCertification is waiting for AB-26-0731

CLinked

Wholesaler #4471 is waiting for 4,000 packs of batch 26-0409: FT-500 to HV-FT500 v9, pressed on T3.

Who?

Customers and teams

  • #4471Wholesaler, Germany, 4,000 packs
  • #4502Wholesaler, Austria, 2,500 packs
  • OE-QA-OPSQA Operations
  • QP-02Qualified Person

ERP, QMSwaiting for this batch

What kind?

Product, instructions, substances

  • FT-500Film-coated tablet 500 mg, Alu/PVdC blister
  • HV-FT500 v9Manufacturing instructions
  • WS-26-0117Active substance batch
  • HS-26-0842Microcrystalline cellulose, new supplier since August

ERP, DMSmade to HV-FT500 v9

Where?

Equipment and storage

  • T3Rotary press, room 2.14
  • C2Coater
  • V2Packaging line with serialisation
  • QL-3Quarantine store

MES, ERPpressed on T3

What’s going on?

Orders, samples, deviations

  • HA-26-1187Manufacturing order
  • L-26-21877Sample for release testing
  • AB-26-0731Deviation at T3, batch 26-0412

MES, LIMS, QMSorder, sample, deviation

Which one exactly?

Batch 26-0409

FT-500 film-coated tablets 500 mg, 15,912 packs of 30

  • Packed on 10 November, in quarantine. The Qualified Person certifies as soon as AB-26-0731 is closed.

ERPFinished batch

What applies?

Authorisation and contracts

  • MA-FT500Marketing authorisation, module 3
  • RV-4471-03Supply contract with wholesaler #4471

DMS, ERPsold under RV-4471-03

What’s in writing?

SOPs, changes, reports

  • SOP-QA-014Deviations and CAPA
  • CC-26-0093Change control: new cellulose supplier
  • PQR-FT500-25PQR of the previous year

DMS, QMSdescribes this batch

What should it be?

Requirements

  • SP-FT500 Rev. 6Assay 95.0 to 105.0%, dissolution Q 80% at 30 min
  • HV-FT500 v9Breaking force 90 to 160 N
  • ST-FT500Stability at 25 °C and 60% RH, 36 months

LIMS, DMSapplies to this batch

What do we make of it?

Findings

  • F-26-211Breaking force within target, close to the limit
  • F-26-212Dissolution 3 points lower since the supplier change, within target

demifinding on this batch

At the pump maker, the pump with its serial number sits in the middle; at the machine builder, the line at the customer’s site. At Rhenalis, it is the batch, packed in 15,912 folding boxes with a serial number each. The grid stays, the middle changes.

DWhat it can do

  • Recognise

    Batch 26-0409 in the ERP, “FT500-0409” in the LIMS and “260409” in the setup log are the same batch.

  • Unify

    “MCC 102”, “cellulose, microcrystalline” and material 200417 become one excipient per Ph. Eur.

  • Trace

    Every value shows its source, exact location and version. Unclear rows are kept too.

  • Look back

    Manufacturing instructions HV-FT500 as they stood on 6 November: version 9.

  • Write back

    After approval, the report lands in the QMS, with person and time in the audit trail.

3Intelligence

Five agents do the work, people approve

  1. PQR agent

    AI coworker, accountable: Head of QA

    TriggerA product’s PQR is in the annual plan
    ReadsBatches and yields in the MES, test results and stability in the LIMS, deviations, CAPA, change controls and complaints in the QMS
    DoesCalculates trends against specification and the previous year, drafts each section from the PQR template, names anomalies and missing data
    ApprovalQA assesses and signs
  2. Deviation agent

    Works for the person who starts it

    TriggerSomeone from QA or manufacturing starts it with a new deviation in the QMS
    ReadsEarlier deviations and CAPA, eBR and IPC values in the MES, setup logs, LIMS results, old reports in the DMS
    DoesFinds similar cases, narrows down the affected batches, drafts report and impact assessment with a source for every sentence
    ApprovalQA classifies and sets the CAPA
  3. Audit agent

    AI coworker, accountable: Head of Audits & suppliers

    TriggerAn inspection, a partner audit or a supplier audit is in the calendar
    ReadsSOPs, training records, qualification and validation reports in the DMS, CAPA and earlier findings in the QMS
    DoesAssigns each question to its GMP chapter, collects the evidence, lists gaps and overdue CAPA
    ApprovalHead of QA approves what the auditor sees
  4. Traceability agent

    AI coworker, accountable: Head of QA Operations

    TriggerComplaint, supplier notification, recall exercise
    ReadsGoods receipts, batches and deliveries in the ERP, weighings in the eBR, serial numbers from serialisation
    DoesBuilds the family tree from the active substance and excipient batch to the wholesaler and back, lists packs and stock
    ApprovalQA decides on hold and recall
  5. Process agent

    AI coworker, accountable: Head of Process Development

    TriggerContinuous: compression force, weight, granule moisture, speed
    ReadsProcess data from granulators and presses, IPC values in the MES, punch changes, excipient batch changes
    DoesKnows the normal state per product, press and punch set, reports drift within the limits, shows similar earlier cases
    ApprovalShift lead and QA decide

A person decides on classification, CAPA and approval, as the SOPs lay down. Rhenalis validates demi like any GxP system under Annex 11 and 21 CFR Part 11. Every access and every change is in the audit trail.

Calculations run on the data from LIMS, MES and QMS, not in the language model. Whatever is written back into a GMP system, a person approves, with an electronic signature.

The roadmap

Next up: certification, more equipment, regulatory affairs and planning

  1. Certification prepared

    Before the certificate, the Qualified Person checks the batch file, lab values, open deviations and change controls. demi puts it all together per batch and shows only what stands out. Certifying stays with them.

    O4
  2. More equipment in view

    After the presses, the coaters and the capsule filling machines: spray rate, inlet air temperature, fill weight. demi reports drift there too, before an IPC value reaches the limit.

    S4
  3. Regulatory affairs, planning and purchasing

    From every change control, the question whether the authorisation needs a variation notification. Plus a weekly plan for six presses that knows cleaning and punch changes, and suppliers with their qualification.

    O1O7

Sources

Why data first, then rights, then AI

60%

Through 2026, Gartner expects organisations to abandon 60% of AI projects that lack AI-ready data.

Gartner · 2025 · on step 1, dataOpen the source (opens in a new tab)
Least privilege

Share sensitive data in LLM apps on a least-privilege basis only, meaning just what a user or process needs.

OWASP GenAI Security Project · 2025 · on step 2, rightsOpen the source (opens in a new tab)
70%

70% of AI’s potential value sits in core functions such as sales, manufacturing and supply chain.

Boston Consulting Group · 2025 · on step 3, intelligenceOpen the source (opens in a new tab)
RhenalisPharmaExample company

Rhenalis doesn’t exist. Your company does.

In 20 minutes we show you demi on a case like yours: bring the data together, set the rights, let AI do the work.

Rhenalis does not exist: a made-up example company from Pharma & Biotech, not a real one. An estimate from our assumptions, not a promise. You can change every number in the configurator.

Your configurator

No use cases yet

Your configurator is still empty

Add a use case from any card or case page and see what it brings per year, with the calculation. Free, no sign-up, no commitment: try it out and change any number.

Browse use cases